Main Article Content
Patients suffering from schizophrenia have an elevated risk for obesity and metabolic syndrome due to multiple factors, including antipsychotic drug consumption. Diet and lifestyle modification remained the firstline modalities for management of obesity in patients with schizophrenia. Metformin has been recommended for preventing weight gain, including for schizophrenic patients with long-term consumption of psychiatric medication.
Download data is not yet available.
This work is licensed under a Creative Commons Attribution 4.0 International License.
World Nutrition Journal is an open acces journal and under the licence of